339 results on '"Steinvil, Arie"'
Search Results
2. Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed Tomography
3. Overview of the 2016 U.S. Food and Drug Administration Circulatory System Devices Advisory Panel Meeting on the Absorb Bioresorbable Vascular Scaffold System
4. Temporal Trends of Transcatheter Aortic Valve Implantation over 12 Years: A High-Volume Single-Center Experience
5. Abstract 18530: Outcomes of Intracoronary Vascular Brachytherapy for Treatment of In-stent Restenosis in the Contemporary Drug-Eluting Stent Era
6. Abstract 16378: Oral Anticoagulation Post Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation
7. Abstract 14884: Frailty Status and Transcatheter Aortic Valve Replacement Outcome Regardless of Society of Thoracic Surgery Risk Score
8. Clinical Predictors for Procedural Stroke and Implications for Embolic Protection Devices during TAVR: Results from the Multicenter Transcatheter Aortic Valve Replacement In-Hospital Stroke (TASK) Study
9. Local Anesthesia versus Conscious Sedation among Patients Undergoing Transcatheter Aortic Valve Implantation—A Propensity Score Analysis
10. Clinical Predictors for Procedural Stroke and Implications for Embolic Protection Devices during TAVR:Results from the Multicenter Transcatheter Aortic Valve Replacement In-Hospital Stroke (TASK) Study
11. Impact of left ventricular filling parameters on outcome of patients undergoing trans-catheter aortic valve replacement
12. Association of Angiotensin-Converting Enzyme Inhibitor Therapy Initiation With a Reduction in Hemoglobin Levels in Patients Without Renal Failure
13. Impact of Valve Size on Paravalvular Leak and Valve Hemodynamics in Patients With Borderline Size Aortic Valve Annulus
14. Overview of the 2016 US Food and Drug Administration Circulatory System Devices Panel Meeting on the AngelMed Guardian System
15. Admission Glucose Levels and the Risk of Acute Kidney Injury in Nondiabetic ST Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
16. Usefulness of Urine Output Criteria for Early Detection of Acute Kidney Injury after Transcatheter Aortic Valve Implantation
17. J-Point Elevation in Survivors of Primary Ventricular Fibrillation and Matched Control Subjects: Incidence and Clinical Significance
18. Impact of Carotid Atherosclerosis on the Risk of Adverse Cardiac Events in Patients With and Without Coronary Disease
19. Assessment of Kidney Function After Transcatheter Aortic Valve Replacement
20. Generational Differences in Outcomes of Self-Expanding Valves for Transcatheter Aortic Valve Replacement.
21. Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Transcatheter Aortic Valve Implantation (TAVI) Patients.
22. P1276 Excess mortality associated with atrial fibrillation complicating tricuspid regurgitation
23. Short-term exposure to air pollution and inflammation-sensitive biomarkers
24. TCT-24 Clinical Predictors for Procedural Stroke and Implications for Embolic Protection Device During TAVR: Results From the Multicenter TASK (Transcatheter Aortic valve implantation in-hoSpital stroKe) Study
25. Forced diuresis with matched hydration during transcatheter aortic valve implantation for Reducing Acute Kidney Injury: a randomized, sham-controlled study (REDUCE-AKI)
26. PROGNOSTIC IMPLICATIONS OF BASELINE PULMONARY VASCULAR RESISTANCE DETERMINED BY TRANSTHORACIC ECHOCARDIOGRAPHY PRIOR TO TRANSCATHETER AORTIC VALVE REPLACEMENT
27. Prognostic implications of small left atria on hospitalized patients
28. Waist circumference as the predominant contributor to the micro-inflammatory response in the metabolic syndrome: a cross sectional study
29. The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome
30. Elevated resting heart rate is associated with the metabolic syndrome
31. Re-Appraisal of Echocardiographic Assessment in Patients with Pulmonary Embolism: Prospective Blinded Long-Term Follow-Up.
32. The Utility of Prophylactic Pacemaker Implantation in Right Bundle Branch Block Patients Pre-Transcatheter Aortic Valve Implantation.
33. Comparison of Platelet Reactivity in Black Versus White Patients With Acute Coronary Syndromes After Treatment With Ticagrelor
34. TCT-91 Antithrombotic therapy post transcatheter aortic valve replacement in patients with no indication for anticoagulation
35. TCT-146 The impact of clinical frailty on one-year mortality post transcatheter aortic valve replacement
36. TCT-786 Antithrombotic Management for Atrial Fibrillation Patient Undergoing Transcatheter Aortic Valve Replacement
37. TCT-147 Short and long term transcatheter aortic valve replacement outcome using clinical frailty status
38. TCT-558 Impact of an electrophysiology study guided PPM implantation strategy after TAVR
39. ACUTE AORTIC REGURGITATION POST-TRANSCATHETER AORTIC VALVE REPLACEMENT: IMPACT OF VARIOUS TREATMENT STRATEGIES
40. RACIAL DISPARITIES AND TEMPORAL TRENDS IN DEMOGRAPHICS AND CLINICAL CHARACTERISTICS OF PATIENTS SCREENED FOR TRANSCATHETER AORTIC VALVE REPLACEMENT
41. ANTITHROMBOTIC THERAPY DIFFERENCES AND ASSOCIATED OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT
42. IN-STENT RESTENOSIS OF DRUG-ELUTING STENTS: INCIDENCE, LESION CHARACTERISTICS AND OUTCOMES IN CONTEMPORARY PRACTICE OVER THE LAST DECADE – HOW ARE THEY DIFFERENT FROM DE NOVO LESIONS?
43. LONG-TERM MORTALITY IN PERCUTANEOUS CORONARY INTERVENTION OF SAPHENOUS VEIN GRAFTS FROM REAL-WORLD REGISTRY DATA
44. IS THERE A ROLE FOR INVASIVE ELECTROPHYSIOLOGY STUDIES IN PATIENTS WITH CONDUCTION ABNORMALITIES FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT?
45. TRENDS IN DISCHARGE AND OUTCOME OF DUAL ANTIPLATELET THERAPY POST PERCUTANEOUS INTERVENTION IN HIGH BLEEDING RISK POPULATION
46. OUTPATIENT TRENDS IN DUAL ANTIPLATELET THERAPY FOLLOWING ACUTE CORONARY SYNDROME AND PRIMARY PERCUTANEOUS CORONARY INTERVENTION
47. CRT-100.76 In-stent Restenosis Of Second-generation Drug-eluting Stents: Incidence, Lesion Characteristics, And Outcomes Over The Last Decade. How Are They Different From De Novo Lesions?
48. CRT-100.48 High Bleeding Risk Influences The Type of Stent Used in Patients Presetting with Acute Coronary Syndrome
49. CRT-200.26 Trends in Utilization of Thrombus Aspiration in Primary Percutaneous Coronary Intervention During ST Elevation Myocardial Infarction
50. CRT-800.13 Contemporary Transcatheter Aortic Valve Replacement Experience With Third-generation Balloon-expandable Versus Self-expanding Devices
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.